206 related articles for article (PubMed ID: 26370491)
1. Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis.
Jia XZ; Wang YM; Zhang N; Guo LN; Zhen XL; Li H; Wei L
J Obstet Gynaecol Res; 2015 Nov; 41(11):1791-802. PubMed ID: 26370491
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
Ardabili HR; Gargari BP; Farzadi L
Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis.
Xue Y; Xu P; Xue K; Duan X; Cao J; Luan T; Li Q; Gu L
Arch Gynecol Obstet; 2017 Feb; 295(2):487-496. PubMed ID: 27933387
[TBL] [Abstract][Full Text] [Related]
6. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.
He C; Lin Z; Robb SW; Ezeamama AE
Nutrients; 2015 Jun; 7(6):4555-77. PubMed ID: 26061015
[TBL] [Abstract][Full Text] [Related]
7. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.
Irani M; Minkoff H; Seifer DB; Merhi Z
J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome.
Velija-Ašimi Z
Med Glas (Zenica); 2014 Feb; 11(1):170-6. PubMed ID: 24496360
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
11. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D in the aetiology and management of polycystic ovary syndrome.
Thomson RL; Spedding S; Buckley JD
Clin Endocrinol (Oxf); 2012 Sep; 77(3):343-50. PubMed ID: 22574874
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.
Güdücü N; Görmüş U; Kutay SS; Kavak ZN; Dünder I
Gynecol Endocrinol; 2014 Aug; 30(8):557-60. PubMed ID: 24819314
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Decreases Serum VEGF Correlating with Clinical Improvement in Vitamin D-Deficient Women with PCOS: A Randomized Placebo-Controlled Trial.
Irani M; Seifer DB; Grazi RV; Irani S; Rosenwaks Z; Tal R
Nutrients; 2017 Mar; 9(4):. PubMed ID: 28350328
[TBL] [Abstract][Full Text] [Related]
15. Serum 25-Hydroxy Vitamin D Levels in Turkish Adolescent Girls with Polycystic Ovary Syndrome and the Correlation with Clinical/Biochemical Parameters.
Bostanci EI; Ozler S; Yilmaz NK; Yesilyurt H
J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):270-273. PubMed ID: 28782659
[TBL] [Abstract][Full Text] [Related]
16. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.
Selimoglu H; Duran C; Kiyici S; Ersoy C; Guclu M; Ozkaya G; Tuncel E; Erturk E; Imamoglu S
J Endocrinol Invest; 2010 Apr; 33(4):234-8. PubMed ID: 19820295
[TBL] [Abstract][Full Text] [Related]
17. Is there association between vitamin D levels, apelin 36, and visfatin in PCOS?
Kiyak Caglayan E; Engin-Üstun Y; Sari N; Göçmen AY; Seckin L; Kara M; Metin A; Polat MF
Gynecol Endocrinol; 2016; 32(5):386-9. PubMed ID: 26732135
[TBL] [Abstract][Full Text] [Related]
18. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review.
Krul-Poel YH; Snackey C; Louwers Y; Lips P; Lambalk CB; Laven JS; Simsek S
Eur J Endocrinol; 2013 Dec; 169(6):853-65. PubMed ID: 24044903
[TBL] [Abstract][Full Text] [Related]
19. [The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders].
Brzozowska M; Karowicz-Bilińska A
Ginekol Pol; 2013 Jun; 84(6):456-60. PubMed ID: 24032264
[TBL] [Abstract][Full Text] [Related]
20. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
